H.C. Wainwright initiated coverage on AEON Biopharma with a new price target
$AEON
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright initiated coverage of AEON Biopharma with a rating of Buy and set a new price target of $18.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/18/2023 | $18.00 | Buy | H.C. Wainwright |